IP Library Assignment 073056/0214
Patent Assignment
Reel/Frame 073056/0214

Security Interest

Recorded: 2025-10-08 Pages: 16
Assignors
BEREN THERAPEUTICS P.B.C.
Executed: 2025-10-08
MANDOS LLC
Executed: 2025-10-08
Assignee
HERCULES CAPITAL, INC., AS AGENT
1 NORTH B STREET, SUITE 2000, SAN MATEO, CALIFORNIA, 94401
Covered Properties (49)
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Patent: 9,675,634 →
Application: 15/288,876 →
Publication: US 2017/0042932
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 15/499,831 →
Publication: US 2017/0296572
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 16/134,028 →
Publication: US 2019/0038662
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 16/372,899 →
Publication: US 2019/0224231
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 16/430,664 →
Publication: US 2019/0290677
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/036,148 →
Publication: US 2021/0015846
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,464 →
Publication: US 2022/0280550
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,470 →
Publication: US 2022/0273697
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,481 →
Publication: US 2022/0288105
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,487 →
Publication: US 2022/0280551
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,491 →
Publication: US 2022/0280552
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,497 →
Publication: US 2022/0280553
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,505 →
Publication: US 2022/0280554
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/745,516 →
Publication: US 2022/0288106
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/946,670 →
Publication: US 2023/0027884
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 17/970,080 →
Publication: US 2023/0068856
Methods for the Treatment of Cardiovascular Disease with Cyclodextrins
Application: 18/023,325 →
Publication: US 2024/0000826
Methods for the Prevention of Cholesterol Crystal Embolization with Cyclodextrins
Application: 18/043,009 →
Publication: US 2023/0302042
Methods for the Treatment of Cholesterol Crystal Embolization with Cyclodextrins
Application: 18/043,013 →
Publication: US 2023/0330133
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 18/072,260 →
Publication: US 2023/0095371
Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
Application: 18/111,237 →
Publication: US 2023/0265219
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 18/115,897 →
Publication: US 2023/0201247
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 18/115,898 →
Publication: US 2023/0226101
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 18/115,901 →
Publication: US 2023/0226102
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 18/130,132 →
Publication: US 2023/0241094
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 18/141,832 →
Publication: US 2024/0016829
Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
Application: 18/384,643 →
Publication: US 2024/0067760
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 18/533,373 →
Publication: US 2024/0180957
Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
Application: 18/633,063 →
Publication: US 2024/0270877
Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
Application: 18/633,087 →
Publication: US 2024/0287211
Methods for the Treatment of Hypertriglyceridemia with Cyclodextrins
Application: 18/801,161 →
Publication: US 2024/0398849
Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
Application: 18/813,368 →
Publication: US 2024/0409671
Methods for Producing Beta-Cyclodextrins
Application: 18/873,261 →
Publication: US 2026/0028655
Methods for Producing Alpha-Cyclodextrins
Application: 18/873,265 →
Methods for Producing Gamma-Cyclodextrins
Application: 18/873,273 →
Publication: US 2026/0062727
Modular Manufacturing for Pharmaceuticals
Application: 18/874,436 →
Systems and Methods for Manufacturing Hydroxypropyl-Beta-Cyclodextrin
Application: 18/874,525 →
Compositions of Hydroxypropyl-Beta-Cyclodextrin and Methods of Purifying the Same
Application: 18/958,956 →
Publication: US 2025/0092162
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/028,631 →
Publication: US 2025/0170165
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/061,509 →
Publication: US 2025/0195559
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/061,577 →
Publication: US 2025/0186482
Compositions and Methods for Treating Sickle Cell Disease
Application: 19/099,986 →
Publication: US 2026/0041704
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/175,757 →
Publication: US 2025/0255899
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/219,596 →
Publication: US 2025/0281522
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/272,439 →
Publication: US 2025/0352571
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/278,356 →
Publication: US 2025/0345357
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/278,380 →
Publication: US 2025/0345358
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/278,422 →
Publication: US 2025/0345359
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Application: 19/312,906 →
Publication: US 2025/0375470
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 7, 2016
From: MACHIELSE, BERNARDUS NICOLAAS; DARLING, ALLAN
To: VTESSE, INC.
Reel/Frame 039969/0346 →
Assignment of Assignor's Interest Oct 26, 2017
From: MACHIELSE, BERNARDUS NICOLAAS; DARLING, ALLAN
To: VTESSE, INC.
Reel/Frame 043960/0862 →
Security Interest Oct 31, 2017
From: VTESSE INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 043994/0850 →
Release of Security Interest Feb 13, 2018
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: VTESSE INC.
Reel/Frame 044909/0699 →
Notice of Grant of Security Interest in Intellectual Property Feb 13, 2018
From: VTESSE INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 045314/0654 →
Notice of Grant of Security Interest in Intellectual Property Jul 22, 2019
From: VTESSE INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049823/0308 →
Notice of Grant of Security Interest in Intellectual Property Dec 9, 2019
From: MALLINCKRODT LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 051231/0961 →
Security Interest Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Assignment of Assignor's Interest Jul 15, 2021
From: VTESSE LLC
To: MANDOS LLC
Reel/Frame 056872/0369 →
Assignment of Assignor's Interest May 24, 2022
From: VTESSE LLC
To: MANDOS LLC
Reel/Frame 059995/0468 →
Assignment of Assignor's Interest May 24, 2022
From: MACHIELSE, BERNARDUS NICOLAAS; DARLING, ALLAN
To: VTESSE LLC
Reel/Frame 059995/0425 →
Release of Security Interest Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Assignment of Assignor's Interest Sep 25, 2022
From: VTESSE LLC
To: MANDOS LLC
Reel/Frame 061206/0257 →
Assignment of Assignor's Interest Sep 25, 2022
From: MACHIELSE, BERNARDUS NICOLAAS; DARLING, ALLAN
To: VTESSE LLC
Reel/Frame 061206/0250 →
Assignment of Assignor's Interest Dec 20, 2022
From: VTESSE, INC.
To: MANDOS LLC
Reel/Frame 062157/0177 →
Assignment of Assignor's Interest Dec 20, 2022
From: MACHIELSE, BERNARDUS NICOLAAS; DARLING, ALLAN
To: VTESSE, INC.
Reel/Frame 062157/0131 →
Release of Patent Security Interests Recorded at Reel 051231, Frame 0961 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0811 →
Release of Patent Security Interests Recorded at Reel 049823, Frame 0308 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0737 →
Assignment of Assignor's Interest Aug 23, 2024
From: KERWIN, DIANA; CAMM, JASON
To: BEREN THERAPEUTICS P.B.C.
Reel/Frame 068385/0969 →
Release of Security Interest Jul 14, 2025
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: VTESSE INC.
Reel/Frame 071937/0425 →